Suppr超能文献

在一项双盲、安慰剂对照研究中,使用由溴化钾、溴化钠、硫酸镍和氯化钠组成的低剂量口服顺势疗法药物对脂溢性皮炎进行有效治疗。

Effective treatment of seborrheic dermatitis using a low dose, oral homeopathic medication consisting of potassium bromide, sodium bromide, nickel sulfate, and sodium chloride in a double-blind, placebo-controlled study.

作者信息

Smith Steven A, Baker Ardith E, Williams John H

机构信息

Loma Lux Laboratories, Tulsa, OK, USA.

出版信息

Altern Med Rev. 2002 Feb;7(1):59-67.

Abstract

BACKGROUND

Topical over-the-counter remedies exist to aid in the control of seborrheic dermatitis and chronic dandruff on a superficial level. Low-dose systemic oral nickel and bromide therapy has shown promise in providing improvement and eventual clearing of the disease.

OBJECTIVE

The purpose of this study was to further evaluate the effect of an orally administered low-dose, homeopathic mineral therapy (Potassium bromide 1X, Sodium bromide 2X, Nickel sulfate 3X, Sodium chloride 6X) on seborrheic dermatitis and chronic dandruff.

METHODS

Forty-one patients with seborrheic dermatitis and/or chronic dandruff were assigned to one of two treatment groups: Active (containing the medication) or placebo (vehicle). Study medication was administered in a placebo-controlled, randomly-selected, double-blind study for 10 weeks. At the end of 10 weeks all patients crossed over to the active medication, under a different label for an additional 10 weeks in an open study format.

RESULTS

Twenty-nine patients completed the 10-week blinded portion of the study. After 10 weeks of treatment, the disease state of the active patients improved significantly over that of the placebo patients (p<0.04). The placebo patients' condition before and after crossover to active treatment was also evaluated, showing significant improvement (p<0.01) 10 weeks after crossing over to active medication.

CONCLUSION

Oral therapy using a low-dose homeopathic preparation combining Potassium bromide 1X, Sodium bromide 2X, Nickel sulfate 3X, and Sodium chloride 6X, provides significant improvement in seborrheic dermatitis and dandruff after 10 weeks of dosing.

摘要

背景

市面上存在非处方外用药物,可在浅表层面辅助控制脂溢性皮炎和慢性头皮屑。低剂量系统性口服镍和溴化物疗法已显示出有望改善并最终清除该疾病。

目的

本研究的目的是进一步评估口服低剂量顺势疗法矿物质疗法(溴化钾1X、溴化钠2X、硫酸镍3X、氯化钠6X)对脂溢性皮炎和慢性头皮屑的疗效。

方法

41例患有脂溢性皮炎和/或慢性头皮屑的患者被分配到两个治疗组之一:活性组(含药物)或安慰剂组(赋形剂)。在一项安慰剂对照、随机选择的双盲研究中给予研究药物,为期10周。在10周结束时,所有患者转换为活性药物,以开放研究形式使用不同标签再治疗10周。

结果

29例患者完成了研究的10周盲法部分。治疗10周后,活性组患者的疾病状态较安慰剂组患者有显著改善(p<0.04)。还评估了安慰剂组患者转换为活性治疗前后的情况,结果显示转换为活性药物10周后有显著改善(p<0.01)。

结论

口服低剂量顺势疗法制剂(溴化钾1X、溴化钠2X、硫酸镍3X和氯化钠6X)联合用药10周后,脂溢性皮炎和头皮屑有显著改善。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验